← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-02-11

Drug application

FDA Application #

ANDA209621

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN SULFATE

Generic name

TOBRAMYCIN

Active ingredients

TOBRAMYCIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Gland Pharma Limited

First approval

2021-02-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown